PLX9486 +/- PLX3397

Plexxikon MOA PLX9486-PLX3397

Targeted Indication Status Sites link to clinicaltrials.gov

Gastrointestinal
stromal tumors

Phase 1b/2a

San Antonio, TX
Miami, FL
Detroit, MI
Boston, MA
Los Angeles, CA
Durham, NC
New York, NY

NCT02401815

These compounds and/or uses are investigational and have not been approved by the FDA or any other regulatory authority for the uses under investigation. Image above depicts proposed targeted pathway of the investigational agent(s) in the targeted indication.

Demetri DG et al. Lancet. 2013; 381(9863).
Data on file.